Skip to main content
Fig. 12 | Cancer Nanotechnology

Fig. 12

From: Formulation and optimization of folate-bovine serum albumin-coated ethoniosomes of pterostilbene as a targeted drug delivery system for lung cancer: In vitro and in vivo demonstrations

Fig. 12

A Immunohistochemistry analyzed caspase-3 in lung sections: a lung cancer group (positive control group), b healthy normal mice without treatment (negative control group), c lung cancer group treated with FA-BSA-ENs of PTS, d control group treated with FA-BSA-ENs of PTS, e lung cancer group treated with PTS-loaded ENs, f control group treated with PTS-loaded ENs, g lung cancer group treated with free PTS, h control group treated with free PTS (X: 400 bar 50 μm). B Statistical analysis of % caspase-3 expression of lung sections of treated groups vs. positive control group (****: p-value < 0.0001, ***: p-value < 0.001, **: p-value < 0.01)

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us